Proteomic analysis of human breast cell lines using SELDI-TOF MS shows that mixtures of estrogenic compounds exhibit simple similar action (concentration additivity)
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
Endocrine modulating chemicals in the environment are possible causative agents of a number of human diseases. Many of these compounds act on the same molecular target, and hence risk assessment requires consideration of their possible combined effects. Here, we studied the combined effects of 17beta-estradiol, genistein, bisphenol A and endosulfan on MCF-7 cells. Full concentration-effect curves for cell proliferation were obtained for each compound and used to identify appropriate concentrations for investigating the effects of binary mixtures of the compounds. Protein profiling by surface-enhanced laser desorption/ionization time of flight mass spectrometry was performed to identify responsive proteins. Treatment with each of the compounds produced similar protein profile changes. Prominent and consistent changes were seen in 12 protein ions. Cell proliferation and protein levels responded monotonically to the estrogens, with identifiable no observable effect concentrations in all cases. Binary mixtures of the compounds produced effects on cell proliferation and on each of the responsive protein ions that were fully consistent with concentration additivity. Thus, no reason to deviate from the application of the principles of dose-response and dose additivity in the risk assessment of combinations of estrogenic compounds was found in this study.Citation
Zhu, Z., Edwards, R.J., Boobis, A.R. (2008) 'Proteomic analysis of human breast cell lines using SELDI-TOF MS shows that mixtures of estrogenic compounds exhibit simple similar action (concentration additivity)' Toxicol. Lett. 181 (2):93-103Publisher
ElsevierJournal
Toxicology lettersPubMed ID
18675332Additional Links
http://www.ncbi.nlm.nih.gov/pubmed/18675332Type
ArticleLanguage
enISSN
0378-4274ae974a485f413a2113503eed53cd6c53
10.1016/j.toxlet.2008.07.006
Scopus Count
Collections
Related articles
- A proteomic (SELDI-TOF-MS) approach to estrogen agonist screening.
- Authors: Walker CC, Salinas KA, Harris PS, Wilkinson SS, Watts JD, Hemmer MJ
- Issue date: 2007 Jan
- A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment.
- Authors: Le Moguen K, Lincet H, Marcelo P, Lemoisson E, Heutte N, Duval M, Poulain L, Vinh J, Gauduchon P, Baudin B
- Issue date: 2007 Nov
- Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol.
- Authors: Malorni L, Cacace G, Cuccurullo M, Pocsfalvi G, Chambery A, Farina A, Di Maro A, Parente A, Malorni A
- Issue date: 2006 Nov
- Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.
- Authors: Dowling P, Maurya P, Meleady P, Glynn SA, Dowd AJ, Henry M, Clynes M
- Issue date: 2007 May-Jun
- Effects of the endocrine disruptors atrazine and PCB 153 on the protein expression of MCF-7 human cells.
- Authors: Lasserre JP, Fack F, Revets D, Planchon S, Renaut J, Hoffmann L, Gutleb AC, Muller CP, Bohn T
- Issue date: 2009 Dec